These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20360322)

  • 1. The shape of things to come in attention deficit hyperactivity disorder.
    Shaw P
    Am J Psychiatry; 2010 Apr; 167(4):363-5. PubMed ID: 20360322
    [No Abstract]   [Full Text] [Related]  

  • 2. Attention deficit hyperactivity disorder (ADHD): improved understanding and novel drug treatment.
    Marsden CA
    Neuropharmacology; 2009 Dec; 57(7-8):577-8. PubMed ID: 19733580
    [No Abstract]   [Full Text] [Related]  

  • 3. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.
    Stahl SM
    J Clin Psychiatry; 2010 Jan; 71(1):12-3. PubMed ID: 20129003
    [No Abstract]   [Full Text] [Related]  

  • 6. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.
    Carrey NJ; MacMaster FP; Gaudet L; Schmidt MH
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):11-7. PubMed ID: 17343550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.
    Del Campo N; Chamberlain SR; Sahakian BJ; Robbins TW
    Biol Psychiatry; 2011 Jun; 69(12):e145-57. PubMed ID: 21550021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
    Emond V; Joyal C; Poissant H
    Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholamine modulators: lessons from nonhuman primates.
    Castellanos FX; Kelly C
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):977-9. PubMed ID: 20855042
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiology of NSS in ADHD.
    Pasini A; D'agati E
    World J Biol Psychiatry; 2009; 10(4 Pt 2):495-502. PubMed ID: 19337883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in structural and functional brain imaging studies of attention-deficit/hyperactivity disorder.
    Kelly AM; Margulies DS; Castellanos FX
    Curr Psychiatry Rep; 2007 Oct; 9(5):401-7. PubMed ID: 17915080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX; Acosta MT
    Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal amygdalar activation and connectivity in adolescents with attention-deficit/hyperactivity disorder.
    Posner J; Nagel BJ; Maia TV; Mechling A; Oh M; Wang Z; Peterson BS
    J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):828-37.e3. PubMed ID: 21784302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment.
    Pliszka SR; Glahn DC; Semrud-Clikeman M; Franklin C; Perez R; Xiong J; Liotti M
    Am J Psychiatry; 2006 Jun; 163(6):1052-60. PubMed ID: 16741206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder.
    Ivanov I; Bansal R; Hao X; Zhu H; Kellendonk C; Miller L; Sanchez-Pena J; Miller AM; Chakravarty MM; Klahr K; Durkin K; Greenhill LL; Peterson BS
    Am J Psychiatry; 2010 Apr; 167(4):397-408. PubMed ID: 20123910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared and disorder-specific prefrontal abnormalities in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure CD during interference inhibition and attention allocation.
    Rubia K; Halari R; Smith AB; Mohammad M; Scott S; Brammer MJ
    J Child Psychol Psychiatry; 2009 Jun; 50(6):669-78. PubMed ID: 19236528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry.
    Teicher MH; Anderson CM; Polcari A; Glod CA; Maas LC; Renshaw PF
    Nat Med; 2000 Apr; 6(4):470-3. PubMed ID: 10742158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF
    J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.